Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Integene International

Integene International
Out of Business LATEST DEAL TYPE

Developer of a platform technology for treatments of vascular diseases. The company develops a technology for the treatment of cardiovascular ischemic disease using combinations of gene and stem cell procedures.

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 1951 North West 7th Avenue
  • Suite 300
  • Miami, FL 33136
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Integene International’s full profile, request a free trial.

Integene International Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Oct-2017 00000 Completed Out of Business
3. Accelerator/Incubator 13-Aug-2014 00000 00000 Completed Startup
2. Angel (individual) Completed Startup
1. Grant $10M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Integene International Executive Team (3)

Name Title Board
Jimmy DeMesa MD Chief Executive Officer
Keith Webster Ph.D Founder & Chief Scientific Officer
Michael Gold Vice President & Executive Chairman

Integene International Board Members (3)

Name Representing Role Since Contact
Eduardo De Marchenna MD Integene International Board Member 000 0000
Marvin Sackner MD Integene International Board Member 000 0000
Michael Gold Integene International Vice President & Executive Chairman 000 0000